Pathology News | Tissuepathology.com

Gilead and Nucleai probe why target-positive tumors can still resist ADCs

Erica Goodpaster — Tue, 18 Aug 2026 12:06:42 +0000

Nucleai, Gilead, and target-positive tumors Antibody-drug conjugates (ADCs) have emerged as one of the busiest and most crowded niches within oncology, given their potential to use an antibody to ferry a potent cytotoxic payload toward tumor cells. The class now spans about 15 FDA-approved products, and the segment is growing steadily. Evaluate Pharma projects the ADC category […]

The post Gilead and Nucleai probe why target-positive tumors can still resist ADCs first appeared on Tissuepathology.com.

Global Leader in Digital Pathology AI Healthcare — aetherAI (7803) Officially Lists on the Taiwan Innovation Board

Erica Goodpaster — Fri, 14 Aug 2026 18:53:56 +0000

aetherAI: Delivering Integrated Software-and-Hardware Consulting Solutions for the Global Digital Transformation of Pathology — Growth Momentum Poised to Accelerate aetherAI (7803), a global leader in digital pathology and AI healthcare solutions, officially began trading on the Taiwan Innovation Board on May 20 at an offering price of NT$23.12 per share. A listing ceremony and opening […]

The post Global Leader in Digital Pathology AI Healthcare — aetherAI (7803) Officially Lists on the Taiwan Innovation Board first appeared on Tissuepathology.com.

Techcyte and elea Bring AI-Native Pathology Reporting into Techcyte FusionⓇ

Erica Goodpaster — Fri, 14 Aug 2026 12:23:46 +0000

The partnership brings elea’s pathology-specific AI directly into Techcyte Fusion, enabling pathologists to turn assessments into structured, coded reports. OREM, UT, UNITED STATES, August 13, 2026 /EINPresswire.com/ — Techcyte today announced the availability of eleaDNAi, elea’s AI-native pathology reporting technology, into Techcyte Fusion®, the digital pathology platform that brings anatomic and clinical pathology into a […]

The post Techcyte and elea Bring AI-Native Pathology Reporting into Techcyte FusionⓇ first appeared on Tissuepathology.com.

Smart In Media: Is Grossing part of your Digital Pathology Workflow?

Erica Goodpaster — Thu, 13 Aug 2026 12:23:36 +0000

From Smart In Media: Scanners, image management systems and AI are transforming pathology. Yet one critical step often remains disconnected from the digital workflow: the grossing station. Gross images may be captured separately, named manually or stored in different locations. As a result, valuable information is not always immediately available—or clearly linked to the correct […]

The post Smart In Media: Is Grossing part of your Digital Pathology Workflow? first appeared on Tissuepathology.com.

Proscia: Keeping Digital Pathology Open: The Regulatory Framework Behind Concentriq AP-Dx

Erica Goodpaster — Wed, 12 Aug 2026 12:57:04 +0000

From the Proscia blog: Interoperability in digital pathology is about more than the ability to open an image file. It means giving pathologists a consistent, trusted experience as laboratories add scanners, displays, and connected systems. Selecting a digital pathology platform for primary diagnosis is a long-term, important decision impacting lab operations and the patients who […]

The post Proscia: Keeping Digital Pathology Open: The Regulatory Framework Behind Concentriq AP-Dx first appeared on Tissuepathology.com.

Leica Biosystems Enables Faster Cancer Diagnoses Through Multiple Digital Pathology FDA Clearances, Including Industry-First AI-Assisted Quality Control Software

Erica Goodpaster — Tue, 11 Aug 2026 12:56:37 +0000

Leica Biosystems: Portfolio expansion marks new era for diagnosis delivery, translating digital pathology innovation to clinical impact by accelerating workflows and patient care VISTA, Calif., August 11, 2026 – Leica Biosystems, a Danaher company and a global leader in end-to-end anatomic and digital pathology solutions, today announced multiple U.S. Food and Drug Administration (FDA) 510(k) clearances […]

The post Leica Biosystems Enables Faster Cancer Diagnoses Through Multiple Digital Pathology FDA Clearances, Including Industry-First AI-Assisted Quality Control Software first appeared on Tissuepathology.com.